Victor Temime, Omar M Ghanem, Julie K Heimbach, Tayyab S Diwan, Hadrien Tranchart, Hussein Abdallah, Claire Blanchard, Marie Lontrichard, Fabian Reche, Anne-Laure Borel, Amanda Belluzzi, Mirto Foletto, Emilio Manno, Tigran Poghosyan, Andrea Chierici, Antonio Iannelli
BACKGROUND: The obesity epidemic has led to an increase in the proportion of patients with chronic liver disease due to metabolic associated steatosic liver disease and in the prevalence of obesity in patients with cirrhosis. Metabolic and bariatric surgery has been proven to determine weight loss, obesity-related medical problems remission, and liver steatosis, inflammation, and fibrosis improvement. However, cirrhosis and portal hypertension are well-known risk factors for increased morbidity and mortality after surgery...
March 18, 2024: International Journal of Surgery